Jardiance is a prescription medicine used to treat Type 2 Diabetes. It contains empagliflozin, which belongs to a class of drugs called SGLT2 inhibitors. Jardiance works by helping the kidneys remove excess glucose from the blood through urine, thereby lowering blood sugar levels. It also provides cardiovascular and kidney protection in certain patients. The tablet is usually taken once daily, with or without food, as directed by a doctor. Common side effects may include increased urination, urinary tract infections, and dehydration. Regular monitoring is important for safe and effective use.